Stephanie Nichols, PharmD, BCPS, BCPP, FCCP
University of New England College of Pharmacy
Titles and Affiliations:
- Associate Professor of Pharmacy Practice, University of New England College of Pharmacy
- Psychiatric and Substance Use Disorder (SUD) Pharmacist at Maine Medical Center, Portland
Stephanie Nichols, PharmD, BCPS, BCPP, FCCP graduated from the University at Buffalo with her Doctor of Pharmacy degree and completed an Inpatient Pharmacy Practice Residency at Maine Medical Center. Dr. Nichols is dual-board certified as a Pharmacotherapy Specialist (BCPS) and a Psychiatric Pharmacist (BCPP) and is a fellow of the American College of Clinical Pharmacy (FCCP). She has received multiple awards for her excellence in clinical practice, teaching, and reasearch. In her role at the University, she is involved in teaching mental health and internal medicine therapeutics, providing experiential education rotations for learners (95 and counting), and mentoring student advisees and residents. In her role at the Health System, she is involved in providing direct patient care to patients with mental illness, providing psychopharmacotherapy consults, teaching patients and other members of the interprofessional team about pharmacotherapy, and participating in population health endeavors, including: development of policies, procedures, and pathways regarding opioid withdrawal, clozapine, ketamine for depression, naloxone, alcohol withdrawal, and P & T formulary reviews of psychotropic medications. While both teaching and practicing pharmacy, Dr. Nichols strives to provide, recommend, and teach evidence-based and value-based medicine. She is also extremely passionate about reducing stigma around mental illness and SUDs. She has co-published over 20 manuscripts in journals including: Pain, J of Psychopharmacology, Pharmacotherapy, Psychosomatics, PLoS ONE, J of Studies on Alcohol and Drugs, Pharmacology, Peer J, and Preventative Medicine. Her research interests include: SUDs, psychotropic polypharmacy, and prevention, detection, and mitigation of psychotropic drug related problems. She is also very active in national clinical pharmacy organizations and serves as an expert consultant for the SAMHS Opioid Response Network (ORN, formerly STR-TA).